Why Not Use Both? | GenomeWeb

Why Not Use Both?

At Albin Paul's microarray blog, he announces that NimbleGen Systems and 454 Life Sciences have teamed up with Baylor College of Medicine to create “sequence capture” technology. The technique combines chips with next-gen sequencing, the end goal being to create a whole-genome human exome microarray that is faster and cheaper than using PCR for selective resequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Top Billing

Bit of Cash

Go Your Own Way

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.